Eli Lilly’s new GLP-1 drug and diversified R&D pipeline could drive healthcare sector inflows and deliver over 40% upside.
Pirtobrutinib significantly improved progression-free survival in untreated CLL/SLL patients compared to standard chemoimmunotherapy in the BRUIN CLL-313 trial. Early trends suggest potential overall ...
Tara Davis-Woodhall and Valarie Allman added their first world outdoor titles on Sunday to their Olympic gold medals. Davis-Woodhall won the long jump in Tokyo with her first of six jumps — 7.08 ...
Eli Lilly’s LLY extraordinary revenue expansion remains anchored in its cardiometabolic franchise, where blockbuster GLP-1 drugs Mounjaro and Zepbound powered $20.6 billion in sales during the first ...
Pirtobrutinib was associated with a statistically significant improvement in PFS compared with bendamustine plus rituximab therapy. Topline data were announced from a phase 3 trial evaluating ...
A breakthrough therapy for advanced breast cancer also works well in the early stages, allegedly improving survival outcomes for patients. Results from the seven-year follow-up are not yet ...
A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. This story was originally published on BioPharma Dive. To ...
"Preventing disease relapse and helping patients live longer is the ultimate goal and a high bar in the adjuvant setting. Achieving a statistically significant OS benefit with just two years of ...
Findings showed abemaciclib plus endocrine therapy statistically significantly improved OS vs endocrine therapy alone after 2 years. Topline data were announced from a phase 3 trial evaluating ...
INDIANAPOLIS, Aug. 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Sept. 8, 2025. Jacob Van Naarden, ...
Eli Lilly and Company (NYSE:LLY) is one of the stocks to watch as Jim Cramer looked at market rationality. Cramer discussed the stock purchases by insiders during the episode. He said: “Or how about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback